Lance Alstodt Bio Restorative Therapies, Inc. (BRTX) insider trading activity

Lance Alstodt is President, CEO, COB of BioRestorative Therapies, Inc.. Currently has a direct ownership of 171,872 shares of BRTX, which is worth approximately $364,368. The most recent transaction as insider was on Mar 18, 2024, when has been sold 17,633 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $24,509. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K

0% 3M change

4.63% 12M change

Total Value Held $364,368

LANCE ALSTODT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2024	SELL Payment of exercise price or tax liability	$24,509 $1.39 p/Share	17,633 Reduced 9.3%	171,872 Common Stock
Sep 15 2023	BUY Open market or private purchase	$3,740 $1.7 p/Share	2,200 Added 1.15%	189,505 Common Stock
Sep 13 2023	BUY Open market or private purchase	$1,224 $1.53 p/Share	800 Added 0.42%	188,105 Common Stock
Sep 06 2023	BUY Open market or private purchase	$5,658 $1.96 p/Share	2,887 Added 1.52%	187,305 Common Stock
Jul 25 2023	BUY Open market or private purchase	$10,248 $2.44 p/Share	4,200 Added 2.23%	184,418 Common Stock
Mar 20 2023	SELL Payment of exercise price or tax liability	$19,648 $2.92 p/Share	6,729 Reduced 3.6%	180,218 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$1,118 $2.99 p/Share	374 Reduced 0.2%	186,947 Common Stock

Feb 01 2023	BUY Open market or private purchase	$1,240 $3.1 p/Share	400 Added 0.21%	187,321 Common Stock
Jan 27 2023	BUY Open market or private purchase	$602 $3.01 p/Share	200 Added 0.11%	186,921 Common Stock
Jan 20 2023	BUY Open market or private purchase	$628 $3.14 p/Share	200 Added 0.11%	186,721 Common Stock
Jan 18 2023	BUY Open market or private purchase	$1,244 $3.11 p/Share	400 Added 0.21%	186,521 Common Stock
Jan 09 2023	BUY Open market or private purchase	$308 $3.08 p/Share	100 Added 0.05%	186,121 Common Stock
Dec 23 2022	BUY Open market or private purchase	$902 $3.01 p/Share	300 Added 0.16%	186,021 Common Stock
Dec 07 2022	BUY Open market or private purchase	$5,382 $2.99 p/Share	1,800 Added 0.96%	185,721 Common Stock
Nov 18 2022	BUY Open market or private purchase	$2,880 $2.88 p/Share	1,000 Added 0.54%	183,921 Common Stock
Sep 22 2022	BUY Open market or private purchase	$584 $2.92 p/Share	200 Added 0.11%	182,921 Common Stock
Jul 12 2022	BUY Open market or private purchase	$2,065 $2.95 p/Share	700 Added 0.38%	182,721 Common Stock
Jun 30 2022	BUY Open market or private purchase	$3,410 $3.1 p/Share	1,100 Added 0.6%	182,021 Common Stock
Jun 16 2022	BUY Open market or private purchase	$2,238 $3.73 p/Share	600 Added 0.33%	180,921 Common Stock
Jun 15 2022	BUY Open market or private purchase	$2,576 $3.68 p/Share	700 Added 0.39%	180,321 Common Stock
Jun 14 2022	BUY Open market or private purchase	$1,955 $3.91 p/Share	500 Added 0.28%	179,621 Common Stock
Jun 13 2022	BUY Open market or private purchase	$790 $3.95 p/Share	200 Added 0.11%	179,121 Common Stock
Jun 08 2022	BUY Open market or private purchase	$428 $4.28 p/Share	100 Added 0.06%	178,921 Common Stock
Jun 01 2022	BUY Open market or private purchase	$920 $4.6 p/Share	200 Added 0.11%	178,821 Common Stock
May 26 2022	BUY Open market or private purchase	$9,504 $3.52 p/Share	2,700 Added 1.49%	178,621 Common Stock

Lance Alstodt

President, CEO, COB

Melville, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Restorative Therapies, Inc. insider buys or sells BRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioRestorative Therapies, Inc.

Track Activities on BRTX

Account